| |
| |
| |
| |
| | | |
|
PR:P01185 | vasopressin-neurophysin 2-copeptin (human) | | | | | |
| | | | |
|
PR:000062030 | vasopressin-neurophysin 2-copeptin sequence variant M1T (human) | | | | | |
| | | | |
|
PR:000064279 | vasopressin-neurophysin 2-copeptin sequence variant P2H (human) | | | | | |
| | | | |
|
PR:000060898 | vasopressin-neurophysin 2-copeptin sequence variant P7L (human) | | | | | |
| | | | |
|
PR:000061376 | vasopressin-neurophysin 2-copeptin sequence variant Q23R (human) | | | | | |
| | | | |
|
PR:000060586 | vasopressin-neurophysin 2-copeptin sequence variant V67A (human) | | | | | |
| |
| |
| | | | |
|
PR:P01185 | vasopressin-neurophysin 2-copeptin (human) | | | | | |
| | | | | |
|
PR:000062030 | vasopressin-neurophysin 2-copeptin sequence variant M1T (human) | | | | | |
| | | | | |
|
PR:000064279 | vasopressin-neurophysin 2-copeptin sequence variant P2H (human) | | | | | |
| | | | | |
|
PR:000060898 | vasopressin-neurophysin 2-copeptin sequence variant P7L (human) | | | | | |
| | | | | |
|
PR:000061376 | vasopressin-neurophysin 2-copeptin sequence variant Q23R (human) | | | | | |
| | | | | |
|
PR:000060586 | vasopressin-neurophysin 2-copeptin sequence variant V67A (human) | | | | | |